The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

WEIGHT loss jabs could banish blues as well as bellies, a study claims. People taking the injections showed “significantly ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to see why there’s currently such ...

The study published in the journal JAMA Ophthalmology focused on semaglutide, the GLP-1 agonist in Novo Nordisk’s diabetes therapy Ozempic ... of suicide, but no strong evidence for a link ...

Adverse reactions to the likes of Ozempic and Wegovy are set to soar by more than 350% in a single year, according to the latest data. Between January and mid-May 2024, some 2,780 reports of ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

Adverse reactions to the likes of Ozempic and Wegovy are set to soar by more than 350% in a single year, according to the latest data.

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...